To determine whether we could apply CRISPR-SONIC to knock-in oncogenic Ras such as HRASG12V to model ICC in vivo, we cloned a HRASG12V donor plasmid with human HRAS sequence (Fig. 3a) [32]. Here, HRAS is linked to intrahepatic cholangiocarcinoma.